DK127975B - Fremgangsmåde til fremstilling af 3-oxo-Δ<4>-19-norsteroider. - Google Patents
Fremgangsmåde til fremstilling af 3-oxo-Δ<4>-19-norsteroider.Info
- Publication number
- DK127975B DK127975B DK50772AA DK50772A DK127975B DK 127975 B DK127975 B DK 127975B DK 50772A A DK50772A A DK 50772AA DK 50772 A DK50772 A DK 50772A DK 127975 B DK127975 B DK 127975B
- Authority
- DK
- Denmark
- Prior art keywords
- norsteroids
- oxo
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/72—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
- C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
- C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/54—Quaternary phosphonium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6527—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms
- C07F9/653—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
- C07J1/0051—Estrane derivatives
- C07J1/0059—Estrane derivatives substituted in position 17 by a keto group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J15/00—Stereochemically pure steroids containing carbon, hydrogen, halogen or oxygen having a partially or totally inverted skeleton, e.g. retrosteroids, L-isomers
- C07J15/005—Retrosteroids (9 beta 10 alfa)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2603/00—Systems containing at least three condensed rings
- C07C2603/02—Ortho- or ortho- and peri-condensed systems
- C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
- C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
- C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
- C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
- C07C2603/16—Benz[e]indenes; Hydrogenated benz[e]indenes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77831468A | 1968-11-22 | 1968-11-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK127975B true DK127975B (da) | 1974-02-11 |
Family
ID=25112933
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK617169AA DK130117B (da) | 1968-11-22 | 1969-11-20 | Isoxazolderivater til anvendelse som mellemprodukter til fremstilling af farmakologisk virksomme 13β-alkylgon-4-en-3-oner. |
| DK617269AA DK129090B (da) | 1968-11-22 | 1969-11-20 | Fremgangsmåde til fremstilling af 3-oxo-Δ<4>-19-norsteroider. |
| DK394671AA DK126655B (da) | 1968-11-22 | 1971-08-12 | Fremgangsmåde til fremstilling af isoxazolderivater. |
| DK50772AA DK127975B (da) | 1968-11-22 | 1972-02-04 | Fremgangsmåde til fremstilling af 3-oxo-Δ<4>-19-norsteroider. |
Family Applications Before (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK617169AA DK130117B (da) | 1968-11-22 | 1969-11-20 | Isoxazolderivater til anvendelse som mellemprodukter til fremstilling af farmakologisk virksomme 13β-alkylgon-4-en-3-oner. |
| DK617269AA DK129090B (da) | 1968-11-22 | 1969-11-20 | Fremgangsmåde til fremstilling af 3-oxo-Δ<4>-19-norsteroider. |
| DK394671AA DK126655B (da) | 1968-11-22 | 1971-08-12 | Fremgangsmåde til fremstilling af isoxazolderivater. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US3700661A (da) |
| JP (1) | JPS5022031B1 (da) |
| AT (8) | AT292695B (da) |
| BE (4) | BE742089A (da) |
| BR (4) | BR6914375D0 (da) |
| CA (2) | CA918669A (da) |
| CH (10) | CH529774A (da) |
| DE (3) | DE1958601A1 (da) |
| DK (4) | DK130117B (da) |
| ES (5) | ES373752A1 (da) |
| FI (1) | FI47572C (da) |
| FR (4) | FR2024920A1 (da) |
| GB (9) | GB1298211A (da) |
| IE (1) | IE33651B1 (da) |
| IL (2) | IL33369A (da) |
| NL (4) | NL6917499A (da) |
| NO (1) | NO133806C (da) |
| PH (2) | PH10667A (da) |
| SE (5) | SE361887B (da) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3984428A (en) * | 1968-11-22 | 1976-10-05 | Hoffmann-La Roche Inc. | Isoxazolyl-substituted perhydrobenzindenes |
| US3994930A (en) * | 1970-08-26 | 1976-11-30 | Hoffmann-La Roche Inc. | 6-(3-Cyanopropyl)-2-vinyl tetrahydropyran-2-ol and its tautomer |
| US3991084A (en) * | 1970-08-26 | 1976-11-09 | Hoffmann-La Roche Inc. | Steroid total synthesis process utilizing a cyanoalkyl A-ring precursor |
| US3873562A (en) * | 1972-06-05 | 1975-03-25 | Hoffmann La Roche | 1-(4-Isoxazolyl)-7-hydroxy-3-heptanones |
| US3873561A (en) * | 1972-06-05 | 1975-03-25 | Hoffmann La Roche | 7-(4-Isoxazolyl)-5-oxo-heptanals |
| US3900491A (en) * | 1972-06-05 | 1975-08-19 | Hoffmann La Roche | 1-(4-isoxazolyl)-7-hydroxy-2-hydroxyimino heptanes |
| US3994926A (en) * | 1973-05-24 | 1976-11-30 | Hoffmann-La Roche Inc. | Aryl ketals of polycyclic oxo compounds and processes |
| US3855209A (en) * | 1973-09-04 | 1974-12-17 | Eastman Kodak Co | Synthesis of indolininium methine dyes |
| US4054583A (en) * | 1976-07-06 | 1977-10-18 | Eli Lilly And Company | Process for converting 2,7-dihydroxy-5-isopropylidene-9-substituted-2,6-methano-3,4,5,6-tetrahydro-2H-1-benzoxocin to trans-1-hydroxy-3-substituted-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo(b,d)pyran-9-one |
| JPH11513022A (ja) * | 1995-08-02 | 1999-11-09 | スミスクライン・ビーチャム・コーポレイション | エンドセリンレセプターアンタゴニスト |
| US6030970A (en) * | 1995-08-02 | 2000-02-29 | Smithkline Beecham Corporation | Endothelin receptor antagonists |
| JP2000504013A (ja) * | 1996-02-01 | 2000-04-04 | スミスクライン・ビーチャム・コーポレイション | エンドセリンレセプターアンタゴニスト |
| US6174906B1 (en) | 1999-10-01 | 2001-01-16 | Smithkline Beecham Corporation | Endothelin receptor antagonists |
-
1968
- 1968-11-22 US US778314A patent/US3700661A/en not_active Expired - Lifetime
-
1969
- 1969-11-12 CH CH1679469A patent/CH529774A/de not_active IP Right Cessation
- 1969-11-12 CH CH350372A patent/CH537942A/de not_active IP Right Cessation
- 1969-11-12 CH CH350272A patent/CH537938A/de not_active IP Right Cessation
- 1969-11-14 CH CH1695669A patent/CH561192A5/xx not_active IP Right Cessation
- 1969-11-14 CH CH217372A patent/CH567490A5/xx not_active IP Right Cessation
- 1969-11-14 CH CH217472A patent/CH568314A5/xx not_active IP Right Cessation
- 1969-11-14 CH CH217272A patent/CH567489A5/xx not_active IP Right Cessation
- 1969-11-14 CA CA067476A patent/CA918669A/en not_active Expired
- 1969-11-17 IL IL33369A patent/IL33369A/en unknown
- 1969-11-18 CH CH107372A patent/CH578547A5/xx not_active IP Right Cessation
- 1969-11-18 CH CH1710469A patent/CH567523A5/xx not_active IP Right Cessation
- 1969-11-19 CH CH1719469A patent/CH574890A5/xx not_active IP Right Cessation
- 1969-11-20 DK DK617169AA patent/DK130117B/da unknown
- 1969-11-20 GB GB56790/69A patent/GB1298211A/en not_active Expired
- 1969-11-20 GB GB00793/71A patent/GB1298216A/en not_active Expired
- 1969-11-20 DK DK617269AA patent/DK129090B/da unknown
- 1969-11-20 CA CA067,962A patent/CA944770A/en not_active Expired
- 1969-11-20 GB GB28140/71A patent/GB1298219A/en not_active Expired
- 1969-11-20 GB GB28138/71A patent/GB1298217A/en not_active Expired
- 1969-11-20 GB GB28139/71A patent/GB1298218A/en not_active Expired
- 1969-11-20 GB GB56792/69A patent/GB1298213A/en not_active Expired
- 1969-11-20 GB GB56793/63A patent/GB1298214A/en not_active Expired
- 1969-11-20 GB GB00792/71A patent/GB1298215A/en not_active Expired
- 1969-11-20 GB GB56791/69A patent/GB1298212A/en not_active Expired
- 1969-11-20 NL NL6917499A patent/NL6917499A/xx unknown
- 1969-11-21 SE SE16037/69A patent/SE361887B/xx unknown
- 1969-11-21 FI FI693380A patent/FI47572C/fi active
- 1969-11-21 NL NL6917557A patent/NL6917557A/xx not_active Application Discontinuation
- 1969-11-21 AT AT877370A patent/AT292695B/de not_active IP Right Cessation
- 1969-11-21 FR FR6940173A patent/FR2024920A1/fr not_active Withdrawn
- 1969-11-21 AT AT1089169A patent/AT304772B/de not_active IP Right Cessation
- 1969-11-21 ES ES373752A patent/ES373752A1/es not_active Expired
- 1969-11-21 AT AT1089069A patent/AT294331B/de not_active IP Right Cessation
- 1969-11-21 ES ES373751A patent/ES373751A1/es not_active Expired
- 1969-11-21 NL NL6917554A patent/NL6917554A/xx unknown
- 1969-11-21 NL NL6917574A patent/NL6917574A/xx unknown
- 1969-11-21 AT AT877270A patent/AT299463B/de not_active IP Right Cessation
- 1969-11-21 DE DE19691958601 patent/DE1958601A1/de active Pending
- 1969-11-21 FR FR6940170A patent/FR2024918A1/fr not_active Withdrawn
- 1969-11-21 DE DE1958600A patent/DE1958600C3/de not_active Expired
- 1969-11-21 SE SE7209181A patent/SE376422B/xx unknown
- 1969-11-21 BR BR214375/69A patent/BR6914375D0/pt unknown
- 1969-11-21 AT AT464671A patent/AT308981B/de active
- 1969-11-21 AT AT1089269A patent/AT295757B/de not_active IP Right Cessation
- 1969-11-21 AT AT1088969A patent/AT292694B/de not_active IP Right Cessation
- 1969-11-21 DE DE19691958608 patent/DE1958608A1/de active Pending
- 1969-11-21 IE IE1575/69A patent/IE33651B1/xx unknown
- 1969-11-21 SE SE16039/69A patent/SE354657B/xx unknown
- 1969-11-21 BR BR214374/69A patent/BR6914374D0/pt unknown
- 1969-11-21 FR FR6940172A patent/FR2030078A1/fr not_active Withdrawn
- 1969-11-21 FR FR6940171A patent/FR2024919A1/fr not_active Withdrawn
- 1969-11-21 BR BR214373/69A patent/BR6914373D0/pt unknown
- 1969-11-21 SE SE16036/69A patent/SE364715B/xx unknown
- 1969-11-21 NO NO4629/69A patent/NO133806C/no unknown
- 1969-11-21 ES ES373753A patent/ES373753A1/es not_active Expired
- 1969-11-21 SE SE16038/69A patent/SE355801B/xx unknown
- 1969-11-21 AT AT899970A patent/AT294832B/de not_active IP Right Cessation
- 1969-11-21 BR BR214372/69A patent/BR6914372D0/pt unknown
- 1969-11-22 JP JP44093897A patent/JPS5022031B1/ja active Pending
- 1969-11-22 ES ES373754A patent/ES373754A1/es not_active Expired
- 1969-11-24 BE BE742089D patent/BE742089A/xx unknown
- 1969-11-24 BE BE742090D patent/BE742090A/xx unknown
- 1969-11-24 BE BE742087D patent/BE742087A/xx unknown
- 1969-11-24 BE BE742088D patent/BE742088A/xx unknown
-
1971
- 1971-08-12 DK DK394671AA patent/DK126655B/da unknown
-
1972
- 1972-02-04 DK DK50772AA patent/DK127975B/da unknown
- 1972-04-21 ES ES401968A patent/ES401968A1/es not_active Expired
-
1973
- 1973-05-28 IL IL42366A patent/IL42366A0/xx unknown
- 1973-08-27 PH PH14967A patent/PH10667A/en unknown
- 1973-08-27 PH PH14968A patent/PH11342A/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK126193B (da) | Analogifremgangsmåde til fremstilling af derivater af substitueret N-amino-indolin. | |
| DK122964B (da) | Fremgangsmåde til fremstilling af 3-amino-4-iod-5-methylisoxazolderivater. | |
| DK127975B (da) | Fremgangsmåde til fremstilling af 3-oxo-Δ<4>-19-norsteroider. | |
| DK123715B (da) | Fremgangsmåde til fremstilling af 4'-demethylepipodophyllotoxin-β-D-alkylidenglucosider. | |
| DK125091B (da) | Fremgangsmåde til fremstilling af 1-hydroxy-2-pyridoner. | |
| DK125852B (da) | Fremgangsmåde til fremstilling af erythromycylamin. | |
| DK122124B (da) | Fremgangsmåde til fremstilling af 2-acyloxythionobenzamider. | |
| DK133430B (da) | Analogifremgangsmåde til fremstilling af 1-carbamoyl-3-aroylpyrrolidiner. | |
| DK123300B (da) | Analogifremgangsmåde til fremstilling af thiophen-3-isonitriler. | |
| DK123232B (da) | Analogifremgangsmåde til fremstilling af 3-alkoxy-17α-propinylestra-1,3,5(10)-trien-17β-oler. | |
| DK128540B (da) | Analogifremgangsmåde til fremstilling af pyrazolodiazepinonforbindelser. | |
| DK128008B (da) | Fremgangsmåde til fremstilling af 1-glykosyl-5-azacytosiner. | |
| DK120292B (da) | Analogifremgangsmåde til fremstilling af 2-aryloksymetylpiperazinderivater. | |
| DK123353B (da) | Analogifremgangsmåde til fremstilling af 6,7-methylen-20-spirox-4-en-3-on-forbindelser. | |
| DK122129B (da) | Analogifremgangsmåde til fremstilling af N,N'-dialkyl-4-phenylimidazolin-2-thioner. | |
| DK140726B (da) | Fremgangsmåde til fremstilling af delta2-cephalosporin-forbindelser. | |
| DK122816B (da) | Analogifremgangsmåde til fremstilling af 3-aryl-5-methylhydantoiner. | |
| DK140284B (da) | Analogifremgangsmåde til fremstilling af oxazinobenzodiazepiner. | |
| DK123818B (da) | Fremgangsmåde til fremstilling af 14β-hydroxy-card-20(22)-enolider eller -bufa-20,20-dienolider. | |
| DK129197B (da) | Fremgangsmåde til fremstilling af 10-carbonhydridsubstituerede 5-hydroxy-13β-alkyl-Δ<9(11)>-gonener. | |
| DK118129B (da) | Fremgangsmåde til fremstilling af card-20(22)-enolid-3β-tridesoxypyranosider. | |
| DK128212B (da) | Analogifremgangsmåde til fremstilling af thienylacetamider. | |
| DK121440B (da) | Analogifremgangsmåde til fremstilling af 2,4-bis-morpholino- eller-thiomorpholino-5-carbalkoxy-pyrimidiner. | |
| DK131291B (da) | Fremgangsmåde til fremstilling af hexaorganoditinforbindelser. | |
| DK119555B (da) | Fremgangsmåde til fremstilling af 37β-hydroxy-Δ<4>-androsten- eller -ostrenderivater. |